Search results for "General Pharmacology"

showing 10 items of 356 documents

Ventilator-Associated Pneumonia in Patients with COVID-19: A Systematic Review and Meta-Analysis

2021

The aim of this systematic review and meta-analysis was to estimate the pooled occurrence of ventilator-associated pneumonia (VAP) among patients admitted to an intensive care unit with COVID-19 and mortality of those who developed VAP. We performed a systematic search on PubMed, EMBASE and Web of Science from inception to 2nd March 2021 for nonrandomized studies specifically addressing VAP in adult patients with COVID-19 and reporting data on at least one primary outcome of interest. Random effect single-arm meta-analysis was performed for the occurrence of VAP and mortality (at the longest follow up) and ICU length of stay. Twenty studies were included in the systematic review and meta-an…

invasive mechanical ventilationMicrobiology (medical)medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)RM1-950BiochemistryMicrobiologyArticlelaw.inventionventilator-associated pneumonia03 medical and health sciences0302 clinical medicinePrimary outcomelawInternal medicinemedicinePharmacology (medical)In patient030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticsAdult patientsbusiness.industryVentilator-associated pneumoniaCOVID-19030208 emergency & critical care medicinebacterial infections and mycosesmedicine.diseaseIntensive care unitrespiratory tract diseasesmeta-analysisPneumoniaInfectious DiseasesMeta-analysisTherapeutics. PharmacologybusinessAntibiotics
researchProduct

Analytical Research Based on the Use of Low Cost Instrumentation

2019

lcsh:Pharmacy and materia medicaLow Cost InstrumentationComputer scienceAnalytical ResearchResearch basedSystems engineeringlcsh:RS1-441Pharmaceutical ScienceInstrumentation (computer programming)General Pharmacology Toxicology and PharmaceuticsGreen Analytical ChemistryPharmaceutical Sciences
researchProduct

Inhibition of Saccharomyces cerevisiae Pdr5p by a natural compound extracted from Brazilian Red Propolis

2011

Multidrug resistance of cancer cells and pathogenic microorganisms leading to the treatment failure of some forms of cancer or life-threatening bacterial or fungal infections is often caused by the overexpression of multidrug efflux pumps belonging to the ATP-binding cassette transporters superfamily. The multidrug resistance of fungal cells often involves the overexpression of efflux pumps belonging to the pleiotropic drug resistance (PDR) family of ABC transporters. Possibly the best-studied fungal PDR transporter is the multidrug resistance transporter Pdr5p of Saccharomyces cerevisiae. Some research groups have been searching for new inhibitors of these efflux pumps in order to alleviat…

lcsh:RS1-441Biological activityATP-binding cassette transporterDrug resistancePropolisBiologyYeastMultiple drug resistanceFungicidelcsh:Pharmacy and materia medicaBiochemistryBrazilian Red Propolis multidrug resistance Pdr5p R6G yeastEffluxGeneral Pharmacology Toxicology and Pharmaceutics
researchProduct

Anti-tumor activity of the methanolic extracts of Salvia menthifolia

2012

In the present research we investigated the anti-proliferative activity of Salvia menthifolia Ten. (formerly Salvia menthaefolia), Lamiaceae, on a glioblastoma cell line, since up to date poor therapeutic results have been reported for treatment of malignant glioblastoma. Methanol extracts from different anatomical parts of S. menthifolia were tested on DBTRG-05MG cell line by MTT assay. The most active primary stems extract was also evaluated for apoptosis induction. Results confirmed the anti-tumor property of all the organs and demonstrated that the primary stems extract induced apoptosis after 4 h with the highest values of DNA fragmentation after 6 to 24 h. Some extracts were also HPLC…

lcsh:RS1-441Salvialcsh:Pharmacy and materia medicachemistry.chemical_compoundapoptosis glioblastoma Salvia menthifolia sageCaffeic acidMTT assaySettore BIO/15 - Biologia FarmaceuticaGeneral Pharmacology Toxicology and Pharmaceuticsapoptosis; glioblastoma; Salvia menthifolia; sageapoptosis glioblastomabiologyTraditional medicineRosmarinic acidapoptosisglioblastomaSalvia menthifoliabiology.organism_classificationQuercitrinSettore CHIM/08 - Chimica FarmaceuticasagechemistryBiochemistryPolyphenolSettore BIO/03 - Botanica Ambientale E ApplicataDNA fragmentationLamiaceae
researchProduct

Synthesis, computational evaluation and pharmacological assessment of acetylsalicylic esters as anti-inflammatory agents

2019

A convenient approach to the synthesis of alkyl esters of aspirin (ASA-OR) has been developed. The synthesis of ASA-OR has been realized in two steps: (1) direct esterification of salicylic acid with alcohols in the presence of dicyclohexylcarbodiimide to give alkyl salicylates (SAL-OR); (2) acetylation of SAL-OR with acetyl chloride to yield ASA-OR. Molecular mechanics simulations, performed to calculate the kinetic radii of several ASA-OR, indicated that the pentyl and hexyl acetylsalicylates possess the best properties to cross cell membranes. The in vitro biological tests demonstrate their anti-inflammatory activity, superimposable to that of aspirin. The results of our study suggest th…

medicine.drug_classAcetylsalicylic ester01 natural sciencesAnti-inflammatoryAnti-inflammatory activitychemistry.chemical_compoundAcetyl chlorideAcetylsalicylic acidmedicineGeneral Pharmacology Toxicology and PharmaceuticsAlkylchemistry.chemical_classificationAspirinAspirin010405 organic chemistryAcetylsalicylic acid; Acetylsalicylic esters; Anti-inflammatory activity; Aspirin; Computational study; Pharmacology Toxicology and Pharmaceutics (all); Organic ChemistryOrganic ChemistryCombinatorial chemistry0104 chemical sciences010404 medicinal & biomolecular chemistryMembranechemistryAcetylationPharmacology Toxicology and Pharmaceutics (all)Yield (chemistry)Computational studySalicylic acidmedicine.drug
researchProduct

Anti-phospholipase A2 and anti-inflammatory activity of Santolina chamaecyparissus

2000

The activity of the Santolina chamaecyparissus methanol extract was tested against the phospholipase A2 (PLA2)-induced mouse paw edema and in vitro inhibition of PLA2 activity. After fractionation, only the dichloromethane extract was active against the PLA2 in vitro test. In addition, it reduced the edema induced by arachidonic acid, and by 12-O-tetradecanoylphorbol-13-acetate in a multidose test. After chromatography on silicagel and gel filtration on Sephadex, and using an in vitro anti-PLA2 assay-guided process, we have isolated and identified from the dichloromethane extract the flavone nepetin and four sesquiterpenes.

medicine.drug_classAsteraceaePharmacologyFlavonesPhospholipases AGeneral Biochemistry Genetics and Molecular BiologyAnti-inflammatorySantolina chamaecyparissusMicechemistry.chemical_compoundPhospholipase A2medicineAnimalsEnzyme InhibitorsGeneral Pharmacology Toxicology and PharmaceuticsFlavonoidschemistry.chemical_classificationPlants MedicinalbiologyPlant ExtractsChemistryAnti-Inflammatory Agents Non-SteroidalGeneral Medicinebiology.organism_classificationIn vitroPhospholipases A2BiochemistrySephadexbiology.proteinFemalelipids (amino acids peptides and proteins)Arachidonic acidSesquiterpenesNepetinLife Sciences
researchProduct

Anti-inflammatory activity in mice of extracts from Mediterranean marine invertebrates.

1998

The effects of dichloromethane and methanol extracts from the marine invertebrates Leptogorgia ceratophyta, Holothuria tubulosa, Coscinasterias tenuispina and Phallusia fumigata on carrageenan-induced paw oedema in mice were investigated. The dichloromethane extract of Coscinasterias tenuispina and the methanol extract of Holothuria tubulosa administered p.o. at 50, 100 and 150 mg/kg, inhibited oedema in a dose-dependent manner 3 h after administration of carrageenan. Both extracts partially decreased elastase activity and PGE2 levels measured in homogenates from inflamed paws, without affecting the levels of this prostanoid present in stomach homogenates. As observed with the selective inh…

medicine.drug_classIndomethacinMarine BiologyPharmacologyBiologyCarrageenanGeneral Biochemistry Genetics and Molecular BiologyAnti-inflammatoryDinoprostonechemistry.chemical_compoundMicemedicineAnimalsEdemaGeneral Pharmacology Toxicology and Pharmaceuticschemistry.chemical_classificationPancreatic ElastaseElastaseHolothuria tubulosaAnti-Inflammatory Agents Non-SteroidalGeneral MedicineMarine invertebratesbiology.organism_classificationInvertebratesCarrageenanEnzymechemistryBiochemistryCoscinasterias tenuispinaFemaleCyclo-oxygenaseLife sciences
researchProduct

Targeting a Targeted Drug: An Approach Toward Hypoxia-Activatable Tyrosine Kinase Inhibitor Prodrugs

2016

Tyrosine kinase inhibitors (TKIs), which have revolutionized cancer therapy over the past 15 years, are limited in their clinical application due to serious side effects. Therefore, we converted two approved TKIs (sunitinib and erlotinib) into 2-nitroimidazole-based hypoxia-activatable prodrugs. Kinetics studies showed very different stabilities over 24 h; however, fast reductive activation via E. coli nitroreductase could be confirmed for both panels. The anticancer activity and signaling inhibition of the compounds against various human cancer cell lines were evaluated in cell culture. These data, together with molecular docking simulations, revealed distinct differences in the impact of …

medicine.drug_classPharmacology010402 general chemistry01 natural sciencesBiochemistryArticleTyrosine-kinase inhibitor03 medical and health sciencesNitroreductase0302 clinical medicinetyrosine kinase inhibitorsDrug DiscoverymedicinecancerEpidermal growth factor receptorGeneral Pharmacology Toxicology and PharmaceuticsPharmacologybiologyhypoxiaSunitinibChemistryOrganic ChemistryProdrugtargeted therapeutic0104 chemical sciencesSettore CHIM/03 - Chimica Generale E InorganicaCell culture030220 oncology & carcinogenesisbiology.proteinMolecular MedicineErlotinibprodrugTyrosine kinasemedicine.drugChemMedChem
researchProduct

How to select a biosimilar

2013

In the past few years biosimilars have penetrated the market following the expiry of patents of originator variants. This offers the opportunity to apply high-tech protein products at a lower cost. In contrast to small-molecule generics, clinicians and pharmacists have found it difficult to judge the efficacy and safety profiles of complex protein products. In recent years, the European Medicines Agency (EMA) has gained knowledge on assessing comparability between biosimilars and originator products in scientific and legal areas. This article provides an overview of an extensive set of 31 previously drawn biosimilar selection criteria and describes how several of these criteria are covered …

medicine.medical_specialtyActuarial scienceComplex proteinbusiness.industryAgency (sociology)ComparabilityAlternative medicinemedicineLower costBiosimilarGeneral Pharmacology Toxicology and Pharmaceuticsbusiness
researchProduct

Future perspectives of the pharmacological management of diabetic dyslipidemia

2019

Introduction: Diabetic dyslipidemia is frequent among patients with type 2 diabetes mellitus (T2DM) and is characterized by an increase in triglycerides (TGs), low-density lipoprotein cholesterol (LDL-C), and small-dense (atherogenic) particles, and by a decrease in low high-density lipoprotein cholesterol (HDL-C) and apolipoprotein (Apo) A1 that are strongly related to insulin resistance. The increased flux of free fatty acids from adipose tissue to the liver aggravates hepatic insulin resistance and promotes all of aspects of the dyslipidemic state. Areas covered: Statins are the first-line agents for treatment while other lipid-lowering drugs (ezetimibe, fibrate and proprotein convertase…

medicine.medical_specialtyApolipoprotein Bmedicine.drug_classglucagon like peptide-1 receptor agonist (GLP-1RA)Fibrate030226 pharmacology & pharmacystatins03 medical and health sciences0302 clinical medicineInsulin resistanceEzetimibeInternal medicinemedicineHumansHypoglycemic AgentsPharmacology (medical)General Pharmacology Toxicology and PharmaceuticsOmega 3 fatty acidDyslipidemiasHypolipidemic Agentsfibratebiologybusiness.industrydyslipidemianutritional and metabolic diseasesType 2 Diabetes MellitusGeneral MedicineLipidmedicine.diseasesodium/glucose cotransporter 2 inhibitors (SGLT-2is)LipidsEndocrinologyDiabetes Mellitus Type 2Cardiovascular Diseases030220 oncology & carcinogenesisDipeptidyl peptidase-4 inhibitors (DPP-4is)Dietary Supplementsbiology.proteinKexinlipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase InhibitorHydroxymethylglutaryl-CoA Reductase InhibitorsInsulin ResistancebusinessDyslipidemiamedicine.drugezetimibeproprotein convertase subtilisin/kexin type 9 (PCSK9)
researchProduct